Ignite Creation Date:
2024-05-06 @ 8:28 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06390319
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-20
First Post:
2024-04-25
Brief Title:
Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia ALL Or Lymphoma T-LLY Or Mixed Phenotype Acute Leukemia MPAL
Sponsor:
St Jude Childrens Research Hospital
Organization:
St Jude Childrens Research Hospital
Organization Data
Organization:
St Jude Childrens Research Hospital
Class:
OTHER
Study ID:
SJALL23T
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
St Jude Childrens Research Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| AbbVie | INDUSTRY |